Why HeartBeam, Inc.’s (BEAT) Stock Is Down 6.04%
As of Friday, May 15, HeartBeam, Inc.’s BEAT share price has dipped by 6.04%, which has investors questioning if this is right time to buy.Michael Rose
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
COMPANY SUMMARY
HeartBeam, Inc. operates as a medical technology company that focuses on developing and commercializing electrocardiogram solutions that enable the detection and monitoring of cardiac disease outside a healthcare facility. The company develops HeartBeam System, a cable-free and ambulatory 12L ECG that captures the heart’s electrical signals from three dimensions for high-fidelity data collection and advanced diagnostics for arrhythmia assessment which consists of credit card sized 3D ECG recording device, a patient application, a physician portal, and powerful cloud-based algorithms. HeartBeam, Inc. was incorporated in 2015 and is based in Santa Clara, California.
Commentary & Analysis
Why HeartBeam, Inc.’s (BEAT) Stock Is Down 5.60%
As of Friday, March 20, HeartBeam, Inc.’s BEAT share price has dipped by 5.60%, which has investors questioning if this is right time to buy.Jenna Brashear
Why HeartBeam, Inc.’s (BEAT) Stock Is Down 5.38%
As of Wednesday, March 18, HeartBeam, Inc.’s BEAT share price has dipped by 5.38%, which has investors questioning if this is right time to buy.Jenna Brashear
Why HeartBeam, Inc.’s (BEAT) Stock Is Down 5.51%
As of Monday, March 16, HeartBeam, Inc.’s BEAT share price has dipped by 5.51%, which has investors questioning if this is right time to buy.Jenna Brashear
Why HeartBeam, Inc.’s (BEAT) Stock Is Down 7.48%
As of Friday, March 13, HeartBeam, Inc.’s BEAT share price has dipped by 7.48%, which has investors questioning if this is right time to buy.Cynthia McLaughlin
Financial Summary
| Share Statistics | BEAT | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $22.6 | $421.0 | 11% |
|
| Shares Out (Mil) | 52.8 | 40.7 | 49% |
|
| Institutional Ownership | 50.9% | 83.3% | 36% |
|
| Float (Mil) | 43.7 | 34.5 | 44% |
|
| Beta | -0.79 | 0.85 | 1% |
|
| Avg Daily Volume (000s) | 817 | 277 | 67% |
|
| Price Change (52-week) |
(75.7%) | 64.4% | 10% |
|
| Growth | BEAT | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 11.8% | na |
|
| Net Income (5yr) | (80.4%) | (5.5%) | 3% |
|
| EPS (5yr) | (16.3%) | 10.7% | 17 |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | 43.1% | (15.6%) | 92% |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | na | na | na | |
| Current EPS | na | na | na | |
| Month Ago EPS | na | na | na | |
| # Rev Up | na | na | na | |
| # Rev Down | na | na | na | |
| Three Months Ago EPS | na | na | na | |
| Year/Year Chg | na | na | na | |
| Financials | BEAT | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $141 | na |
|
| Net Income (TTM) (Mil) | ($20) | ($9) | 24% |
|
| EPS (TTM) | ($0.495) | ($0.400) | 28% |
|
| Operating Cash Flow (TTM) (Mil) | ($13) | ($2) | 18% |
|
| Net Cash Flow (TTM) (Mil) | $6 | $1 | 53% |
|
| Long-Term Debt (Q1) (Mil) | $0 | $27 | 0% |
|
| Enterprise Value (Q1) (Mil) | $18 | $418 | 11% |
|
| Valuation | BEAT | Industry Median |
Percentile (All Stocks) |
|
| P/B | 2.67 | 2.50 | 64% |
|
| P/E | na | 27.8 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.5 | na |
|
| Ratios | BEAT | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 59.3% | na |
|
| Net Margin | na | (6.9%) | na |
|
| ROA | (244.3%) | (12.2%) | 1% |
|
| ROE | (328.4%) | (10.7%) | 2% |
|
| Liabilities to Assets | 23.1% | 47.2% | 16% |
|
| F-Score | 3 | 4 | 18% |
|
HeartBeam, Inc. did not pass any screens on 10/27/2026.
